Brian Park, PharmD

All articles by Brian Park, PharmD

FDA Approves Imcivree for Rare Genetic Obesity Disorders

December 9, 2020

The FDA has approved Imcivree™ (setmelanotide; Rhythm Pharmaceuticals) for chronic weight management in patients with obesity due to POMC, PCSK1, or LEPR deficiency.

Microbiome

Microbiome-Derived Therapy Gets Orphan Drug Status for Hepatocellular Carcinoma

Brian Park, PharmD

January 24, 2020

The Food and Drug Administration (FDA) has granted Orphan Drug designation to SFA001 (SFA Therapeutics) for the treatment of hepatocellular carcinoma (HCC).